J&J shuts cardiovascular drug unit
J&J continues to streamline its pharma portfolio
Johnson & Johnson has shut down its pharmaceutical division’s cardiovascular and metabolic unit, marking the second major restructuring in 2 years. The move follows the closure of its infectious disease and vaccine unit last year and primarily affects the sales, marketing, and medical affairs teams, who have already been notified.
What unit has Johnson & Johnson shut down?
Johnson & Johnson has shut down its pharmaceutical division’s cardiovascular and metabolic unit.
Which teams are impacted by Johnson & Johnson’s pharma restructuring?
The restructuring primarily affects the sales, marketing, and medical affairs teams.
When did Johnson & Johnson close its infectious disease and vaccine unit?
Johnson & Johnson closed its infectious disease and vaccine unit in 2023.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.